perjkin elmer

PerkinElmer, Inc. has announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). “Oxford Immunotec’s global role in fighting tuberculosis, particularly its trademark product, the T-SPOT®.TB test, and the operations it has built are remarkable,” said Prahlad Singh, PerkinElmer president and chief executive officer. “We recognize the distinct …